VRXAW — Veraxa Biotech AG - Post de-SPAC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 2079109 ·
Switzerland
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Yahoo Snapshot (yfinance, live)
Total Revenue
$23,426
EBITDA
$-64,244,176
Free Cash Flow
$15,751,170
Enterprise Value
—
Total Cash
—
Total Debt
—
Shares Out
—
Trailing EPS
—
Book Value
$-1.28
ROE
-871.4%
ROA
-50.0%
Div Yield
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.26T | $1415.55 | — |
| JNJ | JOHNSON & JOHNSON | $670.92B | $278.70 | — |
| ABBV | AbbVie Inc. | $517.59B | $292.82 | — |
| MRK | Merck & Co., Inc. | $353.44B | $143.37 | — |
| NVS | NOVARTIS AG | $302.46B | $159.13 | — |
News headlines (Yahoo Finance, 1h cache)
VERAXA Biotech Appoints Raju Willener as Chief Financial Officer
2026-09-04 11:00 · Yahoo
VERAXA Biotech (VRXA), Secarna Partnership Milestone Opens New Potential Market for Conjugation Technology
2026-08-28 19:00 · Yahoo
VERAXA Biotech (VRXA) Builds Antibody-Based Cancer Pipeline Around Dual-Targeting Precision
2026-08-24 18:00 · Yahoo
VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance
2026-08-24 11:00 · Yahoo
VERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies
2026-08-06 18:30 · Yahoo
VERAXA Biotech (VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform
2026-07-30 18:15 · Yahoo
VERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms
2026-07-29 19:30 · Yahoo
VERAXA Biotech (VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline
2026-10-21 19:00 · Yahoo
VERAXA Biotech (VRXA) Presents First In Vivo Proof-of-Concept Data for BiTAC-ADC Platform at World ADC Congress
2026-10-13 19:30 · Yahoo
VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress
2026-10-13 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.